Back

Proenkephalin as a novel prognostic marker in heart failure patients: a meta-analysis

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Biomarkers for heart failure 2 Biomarkers ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Noppachai Siranart

Chulalongkorn University, Bangkok (Thailand)

4 More presentations in this session

Presentation thumbnail
The prognostic role of galectin-3 and endothelial function in patients with heart failure according to left ventricular ejection fraction classification HF group
Miss V. Tsigkou (Athens, GR)
Abstract Slides
Presentation thumbnail
Temporal evolution of the key neurohumoral regulator renin in chronic stable HFrEF
Doctor A. Weidenhammer (Vienna, AT)
Abstract Slides
Presentation thumbnail
Circulating secretoneurin concentrations provide independent prognostic information to established risk indices in patients with chronic heart failure
Professor H. Rosjo (Nordbyhagen, NO)
Abstract Slides
Presentation thumbnail
Proteomic biomarkers associated with incident heart failure and frailty in late life
Doctor D. Ramonfaur (Boston, US)
Abstract Slides

Access the full session

Session thumbnail
Biomarkers for heart failure 2

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources